All Topics — Highlights

FDLI Annual Conference: Exploring Advanced Topics in Food and Drug Law

May 4-5, 2017 | Washington, DC
Register By March 31 and SAVE!

Introduction to U.S. Food Law and Regulation

March 2-3, 2017 | Washington, DC

FDCA Statutory Supplement, 2017

Softbound | 600 pages

21st Century Cures Act

December 21, 2016 | On-Demand Webinar

Continuing the Discourse: FDA’s Public Hearing on Off-Label Communications

November 17, 2016 | Update EXTRA

A First Look at the Deeming Regulations: A Two-Part Webinar

June 15, 2016 | On-Demand Webinar

All Programs
All Resources

All Topics — Programs

Introduction to U.S. Food Law and Regulation

March 2-3, 2017 | Washington, DC

Introduction to U.S. Biologics and Biosimilars Law and Regulation

March 15-16, 2017 | Washington, DC

Introduction to U.S. Tobacco Law and Regulation

April 6, 2017 | Washington, DC
Register By March 9 and SAVE!

Introduction to U.S. Drug Law and Regulation

April 26-27, 2017 | Washington, DC
Register By March 23 and SAVE!

Introduction to U.S. Medical Device Law and Regulation

April 26-27, 2017 | Washington, DC
Register By March 23 and SAVE!

FDLI Annual Conference: Exploring Advanced Topics in Food and Drug Law

May 4-5, 2017 | Washington, DC
Register By March 31 and SAVE!

Introduction to U.S. Drug Law and Regulation

June 14-15, 2017 | Boston, MA
Register By May 11 and SAVE!

Advertising and Promotion Conference: For the Drug, Medical Device, and Veterinary Industries

September 26-27, 2017 | Washington, DC

Introduction to U.S. Tobacco Law and Regulation

October 25, 2017 | Washington, DC

Tobacco Regulation and Policy Conference: For the Tobacco Products Industry

October 26-27, 2017 | Washington, DC

All Topics — Resources

FDCA Statutory Supplement, 2017

Softbound | 600 pages

Early Developments in the Regulation of Biologics

Food and Drug Law Journal | Volume 71 | Number 4

FDA Regulation of Clinical Applications of CRISPR-CAS Gene-Editing Technology

Food and Drug Law Journal | Volume 71 | Number 4

E-cigarette Regulation and Harm Reduction: The Case of Hong Kong

Food and Drug Law Journal | Volume 71 | Number 4

Knowledge Sharing as a Social Dilemma in Pharmaceutical Innovation

Food and Drug Law Journal | Volume 71 | Number 4

FDCA Conviction without Evidence of Knowledge or Intent?

Update Magazine | November/December 2016

A Brave New Food Enforcement World

Update Magazine | November/December 2016

New Antitrust Risks from Introducing New Drugs

Update Magazine | November/December 2016

CRN on the CRN-NAD Advertising Review Program

Update Magazine | November/December 2016

The NAD: A Force in Shaping Food and Dietary Supplement Advertising

Update Magazine | November/December 2016

Interview Amy Rick Talks to Stephen Ubl, PhRMA

Update Magazine | November/December 2016

EU Agrees on New Medical Device and IVD Regulation

Update Magazine | November/December 2016

Continuing the Discourse: FDA’s Public Hearing on Off-Label Communications

November 17, 2016 | Update EXTRA

What’s Missing from MDUFA IV?

October 31, 2016 | Food and Drug Policy Forum

How Will FDA Regulate Off-Label Communications in the Post-Facteau World?

September 26, 2016 | Food and Drug Policy Forum

First Amendment Limits on Compulsory Speech

Food and Drug Law Journal | Volume 71 | Number 3

You Want a Warning with That? Sugar-Sweetened Beverages, Safety Warnings, and the Constitution

Food and Drug Law Journal | Volume 71 | Number 3

Truth, Falsity, and Fraud: Off-Label Drug Settlements and the Future of the Civil False Claims Act

Food and Drug Law Journal | Volume 71 | Number 3

The Law of 180-Day Exclusivity

Food and Drug Law Journal | Volume 71 | Number 3

Pure Powdered Caffeine: Stakeholders Take Measure of FDA’s Warning Letters

February 10, 2016 | Food and Drug Policy Forum

Guide to U.S. Import Requirements for Cosmetics and Other Personal Care Products

FDLI Primer | Downloadable PDF

Bringing Your Pharmaceutical Drug to Market

Softcover | 800 Pages

Food and Drug Law and Regulation, 3rd Edition

Hardbound | 995 Pages

Bringing Your Medical Device to Market, 3rd Edition

Softbound | 450 Pages

All Topics — On Demand Webinars

21st Century Cures Act

December 21, 2016 | On-Demand Webinar

The Yates Memo: A Lawyer’s Professional Responsibility

December 14, 2016 | On-Demand Webinar

Social Media: Innovative Uses and Practical Experiences

November 17, 2016 | On-Demand Webinar

Mandatory GMO Labeling: Preparing for Implementation

August 31, 2016 | On-Demand Webinar

New FDA Nutrition Facts Label: Implications for Industry

June 29, 2016 | On-Demand Webinar

Key Takeaways and Interactions between FSMA’s Final Rules

June 29, 2016 | On-Demand Webinar

A First Look at the Deeming Regulations: A Two-Part Webinar

June 15, 2016 | On-Demand Webinar

New Changes to California’s Prop 65: What Do They Mean for You?

April 21, 2016 | On-Demand Webinar

Open Payments Data and the Sunshine Act: Managing the Risk of Transparency

March 14, 2016 | On-Demand Webinar

Marijuana Regulation in the Food and Drug Realm

February 12, 2016 | On-Demand Webinar

Medical Foods Regulation

February 12, 2016 | On-Demand Webinar